Algernon Pharmaceuticals Inc. C.AGN

Facebook Live with Algernon.......my comments

[talisman47]

Was hoping to hear a discussion on the data ( good and bad ) and for Algernon to provide positive direction on where they are going from here...........came across as I don't think they know where they are going at  this point

Overall the facebook live session came across as lethargic and unenthusiatic on Chris Moreau's and Algernon's part. Nowhere near excited about ifenprodil as he once was. Not offering encouragement or potential positive outlook but more a session of  things don't seem to be working out like we thought, to do more costs money and do these results warrant spending more money , the feeling that FDA may not have intestested in them at this point and no indication or hint of any investors, big pharma interested in the Algernon story.

 I think they are realizing there are issues with ifenprodil being a repurposed drug ( trying to get big pharma to have any interest ) . Don't know if the data results are significant enough to interest them . Repurposing drugs have the positive benefits but there is the negative as well.

They said often before the data that regardless of vaccines coming out that there will always be a need for therapeutics ( now they say it may be harder to find patients for studies and with regards to EUA they suggest with millions of people being vaccinated now that the FDA  may not feel the urgency to look at Algernon and  ifenprodil unless it shows a major significance to help  and show strong enough  data results )

They don't seem to have the desire, the enegy or the money to want to take on a Phase 3........unless they can get funds from other sources ( grants, pharma investors, etc. ).

I try to still be a believer in the company ( have been an investor for over a year ) but without stock movement beyond the 25-35 cent range it gets more difficult. What do we expect to happen over the next 6 months......Chris, if you are reading this give us a plan !!

[Arbourmark]

I am not surprised in their lack of interest and now blaming vaccines and lack of patients for phase 3. The facts are the company currently has a market cap of 22M with 140M shares outstanding. A phase 3 trial could cost as high as $50M, how could they raise $50 M, they would have to double the share count if they could find enough buyers. I don't think management has that kind of

[talisman47]

In their Facebook Life telecast comments today Chris indicated that they had been looking at around $10M for Phase 3 based on approximately 1200 patients which I think is much more realistic than just saying could cost 50M. The data information indicates approx. how many patients should be in a study based on the data points. Still a lot of money ! I like the large study done on repurposing drugs

[Flyer47]

On the upside, there won't be any more dilution, because this clown won't be able to raise another nickel.

[Arbourmark]

Good luck in doing a phase 3 at $10M, I have invested in several pharmas and I can tell you $10M is not realistic. I have seen as low as $30M and as high as $70M.

[GObabyGO1]

Hope some of you listened to me and bailed when it was still in the mid $0.30 range...not looking good...teens by the end of the week? 

[GObabyGO1]

Looks like those teens came quicker then I expected!

[BitHorse]

This post has been removed in accordance with Community Policy